Journal of Clinical Oncology (JCO) Podcast
Episodes
Identifying High-Risk Myeloma
02 Jun 2014
Contributed by Lukas
FISH genetics, LDH and beta 2-microglobulin can identify a group of newly diagnosed myeloma patients with a two-year survival of only 52% in spite of ...
Attempting to Avoid Chemotherapy in CLL with Lenalidomide and Rituximab
27 May 2014
Contributed by Lukas
The current study, reporting on the upfront use of lenalidomide and rituximab in CLL, suggests high response rates and excellent tolerability in young...
Breast Cancer Chemotherapy Effects on Brain Activation During Multitasking and Relation to Cognitive Complaints
27 May 2014
Contributed by Lukas
This podcast summarizes the findings of a recent longitudinal functional MRI study examining the effects of breast cancer chemotherapy on multitasking...
Delayed Diagnostic Lumbar Puncture to Optimize Central-Nervous-System-Directed Therapy in Childhood Acute Lymphoblastic Leukemia
12 May 2014
Contributed by Lukas
This podcast discusses the measures to optimize central-nervous-system-directed therapy in children with acute lymphoblastic leukemia.
Capecitabine Versus Continuous Infusion 5-FU for Rectal Cancer Neoadjuvant Chemoradiation: Equivalent Effectiveness Raises Real-World Questions About Efficacy, Adherence and Economic Implications
05 May 2014
Contributed by Lukas
This trial supports the use of neoadjuvant capecitabine monotherapy as a potentially more convenient radiosensitizer that does not sacrifice surgical ...
Evolving Treatment Paradigms for Primary Mediastinal Diffuse Large B-Cell Lymphoma
05 May 2014
Contributed by Lukas
This podcast reviews the current role of PET and radiotherapy in PMBL.
Response Assessment in Hodgkin Lymphoma: Size Matters!
05 May 2014
Contributed by Lukas
This podcast concerns the potential complimentary role played by PET and CT in the assessment of response in patients with Hodgkin lymphoma.
Second Tumors in PTEN Mutation-Positive Patients: Are They Recurrences or New Primaries?
28 Apr 2014
Contributed by Lukas
Among more than 2,000 patients with an invasive cancer, more than 5% had a mutation in PTEN and almost half of these patients had a second malignancy....
Are Partners of Patients HPV-Positive Oropharyngeal Cancer at Increased Risk of Infection and Cancer?
28 Apr 2014
Contributed by Lukas
This partner study suggests that spouses of people with HPV-positive oropharyngeal cancer do not have elevated oral HPV prevalence and the partners' r...
Planning to Survive: The Role of Physicians
21 Apr 2014
Contributed by Lukas
This JCO podcast provides observations and commentary on the JCO article, "Provision and discussion of survivorship care plans with cancer survivors: ...
Minimal Residual Disease (MRD) Study to Optimize Definition and Therapy of High-Risk Acute Lymphoblastic Leukemia
21 Apr 2014
Contributed by Lukas
The study provides evidence that several patients with high-risk ALL who show a favorable MRD response to chemotherapy can achieve a cure without stem...
Risk-Reducing Oophorectomy in Women with BRCA1 and BRCA2 Mutations: An Opportunity to Personalize Recommendations for Cancer Prevention
31 Mar 2014
Contributed by Lukas
This podcast summarizes and provides clinical conclusions of a large international study on ovarian cancer incidence and outcomes in women with BRCA1 ...
Anti-EGFR Monoclonal Antibodies in the First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The PEAK Experience
31 Mar 2014
Contributed by Lukas
In this podcast, I will discuss first-line usage of anti-EGFR therapies in metastatic colorectal cancer in the context of the PEAK trial findings with...
Accuracy of BRCAPRO in Women with Ovarian Cancer
17 Mar 2014
Contributed by Lukas
This JCO podcast provides commentary on the accompanying JCO article "Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high grade se...
Serious Bevacizumab-Associated Gastrointestinal Toxicity
17 Mar 2014
Contributed by Lukas
This podcast discusses the results of an analysis of the risk of severe gastrointestinal toxicity associated with the administration of bevacizumab to...
The Efficacy of Bevacizumab Combined with Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer Patients and Its Effects On Patient-Reported Outcomes
17 Mar 2014
Contributed by Lukas
Observations from the AURELIA trial evaluating bevacizumab combined with chemotherapy in platinum resistant recurrent ovarian cancer patients and resu...
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
03 Mar 2014
Contributed by Lukas
This JCO podcast provides observations and commentary on the JCO article, Survival, Durable Tumor Remission, and Long-Term Safety in Patients with Adv...
Decision Shared or Otherwise-: The Ongoing Evolution of Local Therapy for Breast Cancer
18 Feb 2014
Contributed by Lukas
Coincident with increased reconstruction with mastectomy are higher rates of mastectomy for early stage cancer and contralateral prophylaxis, suggesti...
Is Early Initiation of Adjuvant Chemotherapy for Breast Cancer Better?
10 Feb 2014
Contributed by Lukas
Early commencement of adjuvant chemotherapy is unlikely to be relevant for the majority of patients but unnecessary delay may be unwise for patients i...
Single Agent Rituximab Active in Nodular Lymphocyte Predominant Hodgkin Lymphoma
10 Feb 2014
Contributed by Lukas
This podcast describes the recent experience of single agent rituximab as management for newly diagnosed and relapsed nodular lymphocyte predominant H...
Adjuvant Treatment for Gastric Cancer: The Story Continues to Evolve
10 Feb 2014
Contributed by Lukas
The mature results of a randomized comparison of S-1 versus observation in Japanese patients who have undergone a D2 resection for gastric cancer cont...
Benefits of Modified Craniospinal Radiation Therapy for Children Treated for Medulloblastoma: Preserving Long-Term Neurocognitive Function
10 Feb 2014
Contributed by Lukas
Children treated for medulloblastoma using reduced dose craniospinal radiation with local tumor bed boost have improved neurocognitive outcomes compar...
Breast MRI As It Is, In Contrast To How We Wish It To Be
06 Jan 2014
Contributed by Lukas
The meta-analysis by Houssami and colleagues notes no recurrence benefit of breast MRI, and adds to a growing body of data demonstrating that the use ...
New Adoptive T Cell Therapy Has EBV-Positive Lymphomas on the Run
16 Dec 2013
Contributed by Lukas
Reflections on a new report describing the successful therapy of lymphomas using adoptively transferred T cells targeting EBV latent membrane proteins...
Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma
16 Dec 2013
Contributed by Lukas
This podcast provides observations and commentary on the study by Payne and colleagues entitled 'Phase II Pilot Study of Intravenous High Dose Interfe...
Some like It Even Hotter: Escalating Radioimmunotherapy in Follicular Lymphoma?
02 Dec 2013
Contributed by Lukas
An increased-dosage radioimmunotherapy for upfront treatment of follicular lymphoma achieves excellent results, raising questions on the best choice o...
Increasing Cytarabine Dose in AML Induction Improves Outcomes in Younger Patients
02 Dec 2013
Contributed by Lukas
This podcast describes the recent experience of high dose cytarabine induction in patients with acute myeloid leukemia (AML), as reported in the EORTC...
The Value of Preoperative MRI in Predicting Outcome in Patients with Rectal Cancer
25 Nov 2013
Contributed by Lukas
MRI done prior to surgery can be useful in determining the long-term outcomes after surgical resection in patients with rectal cancer.
Refining Stringency of Response in Myeloma
18 Nov 2013
Contributed by Lukas
The study by Kapoor et al supports reporting outcome of clinical trials using more stringent uniform response criteria.
When Hodgkin Lymphoma Relapses in The Older Patients
04 Nov 2013
Contributed by Lukas
This podcast reviews outcomes for elderly patients with HODGKIN lymphoma at diagnosis and at the time of relapse.
How Do We Decide Who Should Be Offered a Sentinel Node Biopsy When Their Melanoma Is Less than 1mm in Thickness?
04 Nov 2013
Contributed by Lukas
Sentinel node biopsy should be performed for melanomas greater than or equal to 0.75mm in thickness but not for melanomas less than 0.75mm in thicknes...
FISH for Smoldering Multiple Myeloma
04 Nov 2013
Contributed by Lukas
This podcast discusses Neben and colleagues' paper on FISH findings and smoldering myeloma.
External Beam Accelerated Partial Breast Irradiation: Exploring the Limits of Tolerability
09 Oct 2013
Contributed by Lukas
This JCO Podcast comments on the JCO article, "Interim Cosmetic and Toxicity Results From Rapid: A Randomized Trial Of Accelerated Partial Breast Irra...
Minimal Residual Disease (MRD) in Acute Myeloid Leukemia- Are we Ready for Individualized Risk Assessment Based on MRD?
23 Sep 2013
Contributed by Lukas
Before we can use MRD as a guide of post-remission therapy in AML, we have to standardize our methods for MRD quantification and agree on the definiti...
Functional Imaging as a Biomarker for Survival in Locoregionally Advanced Non-Small Cell Lung Cancer Patients
16 Sep 2013
Contributed by Lukas
ACRIN 6668/RTOG 0235 demonstrates that a post chemoradiotherapy PET scan for locoregionally advanced non-small cell lung cancer can be used as an earl...
EORTC 18961 GMK Vaccine Adjuvant Trial: Unfulfilled Promise for Another Vaccine Trial
09 Sep 2013
Contributed by Lukas
Added to the complexity of the widening variety of vaccines that are in current clinical trial for human cancers, and the increasing sophistication of...
Lenalidomide Monotherapy for Relapsed Mantle Cell Lymphoma
03 Sep 2013
Contributed by Lukas
Lenalidomide is a promising agent for the treatment of mantle cell lymphoma.
Flying Solo: Chemotherapy Without Radiation for Primary Central Nervous System Lymphoma
26 Aug 2013
Contributed by Lukas
The results of CALGB 50202 reported by Rubenstein and colleagues demonstrate the feasibility, safety and efficacy of the MT-R induction and EA consoli...
Second Hematopoietic Transplants for Relapsed AML
05 Aug 2013
Contributed by Lukas
This podcast reviews the biology and treatment of relapse of acute myeloid leukemia following hematopoietic transplantation.
In End-Of-Life Decision-Making, Does DNR Measure Up?
29 Jul 2013
Contributed by Lukas
The ability of an advance care planning discussion to affect end-of-life decisions is tested in a randomized, controlled trial of patients with advanc...
A Clear Answer to the Wrong Question
12 Jul 2013
Contributed by Lukas
The AVAPERL trial reveals a significant improvement in progression-free survival with the combination of pemetrexed/bevacizumab compared with bevacizu...
Bisphosphonate-Related Osteonecrosis of Jaw (BOJN) in the Adjuvant Breast Cancer Setting: Risks and Perspective
24 Jun 2013
Contributed by Lukas
This JCO Podcast provides observations and commentary on the JCO article "Osteonecrosis of the Jaw and Oral Health-Related Quality of Life After Adjuv...
Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?
03 Jun 2013
Contributed by Lukas
Minimal residual disease predicts outcomes in myeloma.
The Prognosis of Breast Cancer Diagnosed During Pregnancy
03 Jun 2013
Contributed by Lukas
This podcast provides an overview and commentary on Amant et al.'s study of breast cancer diagnosed during pregnancy.
The SUCCEED Trial: Maintenance Ridaforolimus for Metastatic Soft- Tissue Sarcomas
30 May 2013
Contributed by Lukas
This podcast provides observations and commentary on the JCO article,"Results of an international randomized phase 3 trial of the mTOR inhibitor, rida...
Who Needs What Therapy? The Elusive Search for Predictive Markers
06 May 2013
Contributed by Lukas
Loss of PTEN expression did not predict resistance to trastuzumab in early stage HER2 positive breast cancer in the large US cooperative group phase I...
Micro RNAs and Other Molecular Markers in AML Therapeutics
06 May 2013
Contributed by Lukas
This podcast describes the current and future use of molecular testing, including micro RNA expression, in the management of AML.
Neuroanatomic and Neuropsychological Outcomes in Adults after Treatment for Childhood Acute Lymphoblastic Leukemia
15 Apr 2013
Contributed by Lukas
This podcast focuses on emerging concerns about adult outcomes in survivors of acute lymphoblastic leukemia treated in childhood and adolescence in th...
HERA Indicates that Adjuvant Trastuzumab Confers Equal Benefit for HER2-Positive Invasive Ductal and Invasive Lobular Breast Cancers
15 Apr 2013
Contributed by Lukas
This Podcast reviews the results of the analysis conducted by Metzger-Filho et al. regarding the benefit of trastuzumab for patients with invasive lob...
New Evidence of the Clinical Significance of Cigarette Smoking by Colon Cancer Patients
01 Apr 2013
Contributed by Lukas
This podcast summarizes findings regarding cigarette smoking and disease-free survival in a Phase III adjuvant colon cancer trial.
Radiotherapy for Pediatric Hodgkin Lymphoma: Are We Ready To Say Goodbye?
18 Mar 2013
Contributed by Lukas
Response after early chemotherapy cycles might identify patients who could safely forgo consolidation with radiotherapy.
Minimal-Intensity Conditioning: A Decade Later
11 Mar 2013
Contributed by Lukas
This podcast reflects on the outcome of minimal intensity conditioning in over 1000 recipients of sibling and unrelated donor transplant.
Evolution of Concurrent Chemoradiation Treatment Approaches in Head and Neck Cancer
05 Mar 2013
Contributed by Lukas
This podcast provides commentary and observations on the long term results summary of RTOG 91-11 in which concurrent chemoradiation was shown to provi...
Off-Label Cancer Therapy Use: How Much is Too Much?
19 Feb 2013
Contributed by Lukas
This podcast reviews findings on the prevalence of off-label cancer therapy use and the estimated costs associated with it.
Caring For Patients With Transformed Follicular Lymphoma
12 Feb 2013
Contributed by Lukas
If transplantation is selected as the treatment approach, the net effect is likely to be similar with allogeneic or autologous transplantation with th...
Outpatient Therapy for Fever and Neutropenia is Safe But Implementation is the Key
28 Jan 2013
Contributed by Lukas
The fluoroquinolone class of antibiotics is a major target for antimicrobial stewardship programs, and the conservation of their effectiveness is impo...
Outcomes in Cancer Survivors Who Develop Second Malignant Neoplasms
22 Jan 2013
Contributed by Lukas
This podcast provides perspective on findings in a large population-based evaluation of overall survival and cancer-specific survival in patients with...
Molecular Profiling of Gastric Cancer: Toward Personalized Cancer Medicine
22 Jan 2013
Contributed by Lukas
One third of gastric cancers harbor genetic or epigenetic alterations in the CDH1 gene, and those with structural changes have a poorer prognosis; gas...
Reflections on "Cancer Survivorship": Evolution, Utility, and Acceptability
03 Jan 2013
Contributed by Lukas
This podcast considers the evolution, utility, and acceptability of the terms 'cancer survivor' and 'cancer survivorship' and comments on a recent art...
Estimating the Risk for Contralateral Breast Cancer as a Guide for Surgical Treatment
03 Jan 2013
Contributed by Lukas
This podcast discusses approaches to risk assessment of contralateral breast cancer and factors which predict the risk.
Revisiting Combination TACE-RFA Treatment for HCC
03 Jan 2013
Contributed by Lukas
Amongst several different liver directed therapy approaches, chemoembolization (called TACE) and radiofrequency ablation (called RFA) are most commonl...
Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma
19 Dec 2012
Contributed by Lukas
A discussion of a phase 2 trial of a MEK inhibitor in patients with V600 BRAF mutations and consideration of other relevant results with targeted ther...
Successful Non-Intensive Bridging of MDS Patients Towards Allografting
19 Dec 2012
Contributed by Lukas
This podcast discusses therapeutic options for MDS patients including azacytidine and allogeneic stem cell transplantation.
Using a Video Decision Support Tool for CPR Decision-Making
11 Dec 2012
Contributed by Lukas
This video support tool describing CPR lets patients make much better informed decisions about the use of CPR. Physicians often feel that CPR will not...
Radioimmunotherapy for the Initial Treatment of Follicular Lymphoma
11 Dec 2012
Contributed by Lukas
Radioimmunotherapy alone or in sequential combination with chemotherapy is effective initial treatment for follicular lymphoma, though comparable (and...
Management of Metastases to the Brain: A Therapeutic Conundrum
03 Dec 2012
Contributed by Lukas
Whole-brain radiation therapy of metastases to the brain is not innocuous - it is associated with decrements in health-related quality of life. It is ...
Understanding the Role of MET Kinase in Cancer Therapy
03 Dec 2012
Contributed by Lukas
This is a commentary on the role of MET in cancer using Choueri et al as an example of rationale therapeutics and translational research.
AIDS Related Lymphomas - More Options and More Questions
19 Nov 2012
Contributed by Lukas
A discussion of treatment approaches for newly diagnosed aggressive AIDS-related lymphomas
Long Term Follow-up of NSABP B-31: How Well Can We Predict Cardiac Toxicity with Trastuzumab?
16 Nov 2012
Contributed by Lukas
Seven year follow up of B-31 demonstrates a striking and reassuring lack of longer-term cardiac events.
More Adjuvant Chemotherapy is Not Always Better
16 Nov 2012
Contributed by Lukas
More adjuvant chemotherapy is not always better for early breast cancer patients - Discussion and consequence for clinical practice.
Hodgkin Lymphoma: Protecting the Victims of Our Success
13 Nov 2012
Contributed by Lukas
The podcast reviews the evolution of staging and treatment of Hodgkin lymphoma, reducing the toxicities and torture while maintaining a high level of ...
Beyond the Plasma Cell: Proteasome Inhibition in Acute Myelogenous Leukemia
02 Nov 2012
Contributed by Lukas
In this podcast, Attar and colleagues explore whether patients aged 60-75 who enter remission with bortezomib added to standard anthracycline plus cy...
Breast Brachytherapy in the United States: Increasing Use Despite Increased Complication Rates
01 Nov 2012
Contributed by Lukas
This podcast will review a JCO article showing that the use of breast brachytherapy as a method of delivering partial breast radiation after breast co...
Referral Practices to Palliative Care Among Canadian Oncologists
01 Nov 2012
Contributed by Lukas
This Podcast provides observations and commentary about referral practices of oncologists to specialized palliative care.
Clinical Utility of Screening Tests in Asymptomatic Long-Term Childhood Cancer Survivors
01 Nov 2012
Contributed by Lukas
This podcast characterizes the clinical utility of the screening tests recommended by the Children's Oncology Group in the care of long-term survivors...
Is Lymphatic Mapping Ready for Clinical Use in the Treatment of Squamous Vulvar Cancer?
30 Oct 2012
Contributed by Lukas
Publication of a large collaborative group trial appears to definitively demonstrate the safety of sentinel lymph node biopsy as replacement for ingui...
Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation: Final Analysis of the CORAL Trial
23 Oct 2012
Contributed by Lukas
In this podcast, results of a randomized phase III clinical trial evaluating the use of Rituximab maintenance therapy following autologous stem cell t...
Informed Consent for Pediatric Phase I Cancer Trials: An End-of-Life Decision
15 Oct 2012
Contributed by Lukas
Melissa Cousino and colleagues found that few parents understand the scientific purpose of phase I pediatric clinical trials.
Outcome in Systemic Anaplastic Large Cell Lymphoma: Beyond ALK
08 Oct 2012
Contributed by Lukas
The prognostic importance of ALK-protein expression was established over a decade ago. More recent studies emphasize that age is also an important dr...
Should Gemtuzumab Ozogamicin Be Re-added to the Therapeutic Armamentarium for Acute Myeloid Leukemia?
17 Sep 2012
Contributed by Lukas
Although gemtuzumab ozogamicin has been withdrawn from the marketplace, three randomized trials prompt review of that decision.
Immunohistochemical Double Hit Score in Diffuse Large B-Cell Lymphoma: The Potential to Screen All Tumors for High-Risk Biology
04 Sep 2012
Contributed by Lukas
This podcast summarizes and places in clinical context two studies describing straightforward immunohistochemical methods to risk-stratify diffuse lar...
In a Sea of Data the Water is Still Murky: Meta-Analysis of Cognition in Breast Cancer
27 Aug 2012
Contributed by Lukas
Cognitive impairment occurs in a subset of breast cancer survivors after chemotherapy but the incidence remains unknown.
KRAS G13D Mutations in Metastatic Colorectal Cancer: Are They Different From Codon 12?
24 Aug 2012
Contributed by Lukas
This podcast discusses the manuscript by Tejpar et al in which patients whose colorectal tumors harbor a specific KRAS mutation, G13D, appear to have ...
Taxane Induced Peripheral Neuropathy: A Continued Challenge but Not a Biomarker of Treatment Efficacy
10 Aug 2012
Contributed by Lukas
Although historically toxicity was often thought to be a biomarker of efficacy, often it appears to be a marker of dose intensity and individual susce...
Is This Nomogram Ready To Roll?
25 Jun 2012
Contributed by Lukas
In this podcast, Dr. Hudis reviews the use of a novel nomogram to predict the benefits of postoperative adjuvant radiation therapy for older women wit...
Adjuvant Chemotherapy in Older Patients with Stage III Colon Cancer
04 Jun 2012
Contributed by Lukas
As oncologists treat an increasing number of older patients with colon cancer, and as treatment options improve for older patients, oncologists should...
The Combination of Bortezomib, Thalidomide, and Dexamethasone in Relapsed Multiple Myeloma
14 May 2012
Contributed by Lukas
This podcast will provide a critical evaluation of the combination of bortezomib, thalidomide, and dexamethasone in relapsed multiple myeloma
Personalized Therapy for Breast Cancer: Is It Really Happening?
09 May 2012
Contributed by Lukas
This Podcast reviews and comments on the use of the National Comprehensive Cancer Network (NCCN) Breast Cancer Outcome Database to demonstrate the act...
Routine Second Pathology Review for Node-Negative Breast Cancer: What is Learned and What is the Effect on Patient Care?
07 May 2012
Contributed by Lukas
This Podcast reviews the design and results of the present study by Kennecke et al. and provides perspective regarding the clinical significance of th...
Pre-Operative Metformin in Early-Stage Breast Cancer
07 May 2012
Contributed by Lukas
This podcast reviews the rationale behind evaluation of metformin as a potential anti-cancer agent in breast cancer and describes the findings of a re...
Fulvestrant and Anastrozole in Combination: FACT or Fiction?
30 Apr 2012
Contributed by Lukas
This podcast reviews the results of the FACT trial in the context of other ongoing and proposed studies of endocrine therapy combinations.
A New Day Dawning for Hodgkin Lymphoma?
30 Apr 2012
Contributed by Lukas
This podcast describes a phase 2 trial brentuximab vedotin in patients with Hodgkin lymphoma that has recurred after autologous hematopoietic stem cel...
The German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow Up of 11 Years: Implications of Long Term Follow Up
23 Apr 2012
Contributed by Lukas
In this study, the implications of long term follow up of the German Rectal Study on clinical practice and future trial design will be discussed.
Carboplatin-Gemcitabine-Bevacizumab: Expanding Treatment Options for Recurrent Platinum Sensitive Epithelial Ovarian Cancer
23 Apr 2012
Contributed by Lukas
Carboplatin-Gemcitabine-Bevacizumab represents an additional regimen to consider for management of recurrent platinum sensitive epithelial ovarian can...
The Use of Adjuvant Therapy in Elderly Patients with Resected Non-Small Cell Lung Cancer (NSCLC)
23 Apr 2012
Contributed by Lukas
This podcast discusses adjuvant therapy in elderly NSCLC patients.
Management and Prevention of Pain Related to Treatment or Disease
16 Apr 2012
Contributed by Lukas
The podcast highlights recent JCO articles that underscore the need for improved assessment and management of cancer and treatment-related symptoms.
1 + 1 = 3. Combined Use of Anti-HER2 Agents in the Neoadjuvant Setting
09 Apr 2012
Contributed by Lukas
The CHER-LOB trial is one of several that has demonstrated that adding lapatinib to trastuzumab and chemotherapy improves on the rates of complete pat...
Management of Low Stage Ovarian Clear Cell Carcinoma
09 Apr 2012
Contributed by Lukas
A reflection on the problems clinicians face when making a decision on how best to advise patients regarding management of early clear cell carcinoma ...
Surviving Childhood Cancer: Defining Risk of Poor Cardiac Outcomes in Early and Middle Adulthood
02 Apr 2012
Contributed by Lukas
This podcast provides observations and commentary on the JCO article "High risk of symptomatic cardiac events in childhood cancer survivors.
No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal Cancer
02 Apr 2012
Contributed by Lukas
This podcast reviews a negative phase III clinical trial of cetuximab combined with chemotherapy in first-line metastatic colorectal cancer and focuse...